• MitMAB for Organoid Endocytosis Research

  2026-09-15

  MitMAB enables a controlled test of dynamin-dependent vesicle uptake in physiologically relevant intestinal organoids. Its greatest value emerges when paired with apical–basal polarity comparisons, time-resolved imaging, and orthogonal viability and trafficking controls.

• MitMAB Workflows for Organoid Uptake Research

  2026-09-14

  MitMAB provides a practical pharmacological perturbation for testing whether dynamin-dependent membrane scission contributes to extracellular vesicle uptake. This workflow translates polarity-aware intestinal organoid findings into controlled endocytosis, membrane remodeling, and intracellular trafficking experiments.

• Novobiocin: From Dual Mechanism to Translation

  2026-09-14

  Novobiocin is more than a legacy antibiotic scaffold: its coordinated effects on bacterial DNA gyrase B, Hsp90, membrane biology, and pathogen survival create a platform for translational research. This article connects mechanistic evidence with assay design, resistance strategy, exposure considerations, and a practical path from discovery experiments to differentiated therapeutic hypotheses.

• TUNEL Assays for Translational Apoptosis Research

  2026-09-13

  A mechanistic and strategic guide to using the TUNEL Apoptosis Detection Kit (DAB) to connect oxidative-stress biology, DNA fragmentation, and translational programmed cell death research.

• Candida EVs, Nrg1, and Hyphal Suppression

  2026-09-12

  This study identifies a concentration-dependent role for Candida albicans extracellular vesicles: accumulated vesicles suppress hyphal development by increasing NRG1 transcription through the SKO1–BRG1 regulatory axis. The same pathway was associated with lower fungal burden and improved survival in a candidemia model, while the findings also define important limits for translating fungal-vesicle biology into laboratory workflows.

• Aminopeptidase Selectivity in ACE Inhibitor Studies

  2026-09-11

  This 1992 study re-evaluated how bestatin and several metallopeptidase inhibitors affect the related cell-surface aminopeptidases AP-A, AP-N, and AP-W. Its main contribution was to show that inhibitor selectivity is highly enzyme-dependent, while certain sulfhydryl ACE inhibitors can also inhibit AP-W and therefore complicate pharmacological interpretation.

• GRE Combination Suppresses Melanogenesis via CREB/MITF

  2026-09-11

  The reference study evaluates glabridin, resveratrol, and ellagic acid as a combined composition with anti-melanogenic, antioxidant, and anti-inflammatory activities in complementary cell-based assays. Its main mechanistic contribution is linking reduced melanin production to inhibition of CREB phosphorylation and the MITF transcriptional program, while also highlighting the need for formal synergy and translational validation.

• Bestatin (Ubenimex) in Mechanism-First Assays

  2026-09-10

  Bestatin (Ubenimex) is a selective aminopeptidase probe with practical value in cancer research, MDR studies, and mechanism-resolved cell assays. This article explains how to use its inhibition profile as an orthogonal control when interpreting viral necroptosis and RIPK3 biology.

• OATP1B3 N-Glycosylation in Extracellular Loops

  2026-09-10

  The reference study maps six N-glycosylation sites on human OATP1B3 and shows that this transporter is more extensively glycosylated than the closely related OATP1B1. Its experiments distinguish the roles of individual glycans from the collective requirement for normal surface trafficking and transport activity, offering a useful framework for studying liver transporter regulation.

• MG-132 Workflows for Apoptosis Mechanism Studies

  2026-09-09

  MG-132, also known as Z-LLL-al, combines cell permeability with proteasome-focused perturbation for apoptosis assays, cell cycle arrest studies, and oxidative stress experiments. This guide connects practical dose–time optimization with the Bclaf1–c-FLIP–TNF pathway to improve mechanistic interpretation in cancer research.

• MitMAB for Causal Endocytosis Assays

  2026-09-09

  MitMAB enables a more rigorous test of dynamin-dependent uptake in intestinal organoid models. This guide translates milk-derived extracellular vesicle findings into practical assay design, controls, and interpretation for intracellular trafficking research.

• MitMAB as a Causal Probe of EV Uptake

  2026-09-08

  MitMAB enables a more rigorous test of dynamin-dependent extracellular vesicle uptake in intestinal organoid models. This article connects milk-derived EV biology with assay topology, causal inference, and practical experimental controls.

• Honokiol Beyond Viability: A Translational Strategy

  2026-09-08

  A mechanistic and strategic framework for evaluating Honokiol in cancer research, integrating NF-κB signaling, oxidative stress, angiogenesis, and the distinction between growth inhibition and cell death.

• GW 4869 for Exosome and Osteogenesis Studies

  2026-09-07

  Use GW 4869 to test whether extracellular-vesicle output, ceramide signaling, or both explain lithium-enhanced osteogenesis in BMSC models. This workflow combines donor-cell perturbation, matched vesicle normalization, and practical controls for distinguishing reduced release from reduced viability or altered cargo.

• Sex Differences in Angiotensin II Hypertension

  2026-09-07

  Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II causes a much larger blood-pressure increase in males than females despite comparable baseline pressure. Gonadectomy, baroreflex testing, and ganglionic blockade linked this divergence to sex-dependent hormonal and sympathetic regulation rather than baseline hemodynamics alone.

544 records 4/37 page Previous Next 12345 下5页 Last page